INTERNATIONAL PATENT: LAEKNA THERAPEUTICS SHANGHAI CO., LTD., LAEKNA PHARMACEUTICAL NINGBO CO., LTD. FILES APPLICATION FOR "MULTISPECIFIC BINDING AGENTS COMPRISING ANTI-FIBROBLAST ACTIVATION PROTEIN (FAP) ANTIBODIES AND ONE OR MORE MONOVALENT LIGAND TRAPS AND USES THEREOF"

GENEVA, July 7 -- LAEKNA THERAPEUTICS SHANGHAI CO., LTD. (5th Floor, 987 Cailun Road, ZhangjiangPudong New Area, Shanghai 201203), LAEKNA PHARMACEUTICAL NINGBO CO., LTD. (3-2-467, 5 Xingbin Road (Lin Li Center), Sino-Italy Ningbo Ecological Park, YuyaoNingbo, Zhejiang 315400) filed a patent application (PCT/CN2024/141963) for "MULTISPECIFIC BINDING AGENTS COMPRISING ANTI-FIBROBLAST ACTIVATION PROTEIN (FAP) ANTIBODIES AND ONE OR MORE MONOVALENT LIGAND TRAPS AND USES THEREOF" on Dec 24, 2024. With publication no. WO/2025/140212, the details related to the patent application was published on Jul 03, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Int...